Clinical Trial Update: A Study to Assess the Safety and Effect of TC-5214 in Patients With Major Depressive Disorder. [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing the safety and effects of TC-5214 in adults with major depressive disorder was terminated; results were posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• TC-5214 (TC-5214)

Snippet

Sponsor: AstraZeneca | Conditions: Major Depressive Disorder | Phase 2 | Status: TERMINATED | Results posted: 2012-10-29